These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 30478788)
1. Factors related to fatalities and clinical progression of Crimean-Congo hemorrhagic fever patients and the effects of IL 28-B gene polymorphism. Aytekin FY; Barut HŞ; Rüstemoğlu A; Atay A; Günal Ö; Duygu F Arch Virol; 2019 Feb; 164(2):547-557. PubMed ID: 30478788 [TBL] [Abstract][Full Text] [Related]
2. Effects of Paraoxonase-1 variants on course of severity and mortality of Crimean-Congo hemorrhagic fever. Karakus N; Yigit S; Duygu F; Barut S; Rustemoglu A; Basol N Gene; 2019 Mar; 687():188-192. PubMed ID: 30465883 [TBL] [Abstract][Full Text] [Related]
3. Is there any relationship between Toll-like receptor 3 c.1377C/T and -7C/A polymorphisms and susceptibility to Crimean Congo hemorrhagic fever? Engin A; Arslan S; Özbilüm N; Bakir M J Med Virol; 2016 Oct; 88(10):1690-6. PubMed ID: 26959380 [TBL] [Abstract][Full Text] [Related]
4. Effect of TLR10 (2322A/G, 720A/C, and 992T/A) polymorphisms on the pathogenesis of Crimean Congo hemorrhagic fever disease. Kızıldağ S; Arslan S; Özbilüm N; Engin A; Bakır M J Med Virol; 2018 Jan; 90(1):19-25. PubMed ID: 28843003 [TBL] [Abstract][Full Text] [Related]
5. Relationship between IFNA1, IFNA5, IFNA10, and IFNA17 gene polymorphisms and Crimean-Congo hemorrhagic fever prognosis in a Turkish population range. Elaldi N; Yilmaz M; Bagci B; Yelkovan I; Bagci G; Gozel MG; Engin A; Bakir M; Dokmetas I J Med Virol; 2016 Jul; 88(7):1159-67. PubMed ID: 26694082 [TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 7 Gln11Leu, c.4-151A/G, and +1817G/T polymorphisms in Crimean Congo hemorrhagic fever. Arslan S; Engin A; Özbilüm N; Bakır M J Med Virol; 2015 Jul; 87(7):1090-5. PubMed ID: 25879168 [TBL] [Abstract][Full Text] [Related]
7. Relationship between NF-κB1 and NF-κBIA genetic polymorphisms and Crimean-Congo hemorrhagic fever. Arslan S; Engin A Scand J Infect Dis; 2012 Feb; 44(2):138-43. PubMed ID: 22066734 [TBL] [Abstract][Full Text] [Related]
8. Association of MCP-1 promotor polymorphism with disease severity of Crimean-Congo hemorrhagic fever. Bagci B; Bagci G; Buyuktuna SA; Elaldi N J Med Virol; 2020 Dec; 92(12):2976-2982. PubMed ID: 32219866 [TBL] [Abstract][Full Text] [Related]
9. Effect of tumour necrosis factor-alpha and interleukin-6 promoter polymorphisms on course of Crimean-Congo hemorrhagic fever in Turkish patients. Yilmaz M; Elaldi N; Bagci B; Sari I; Gümüs E; Yelkovan I J Vector Borne Dis; 2015 Mar; 52(1):30-5. PubMed ID: 25815864 [TBL] [Abstract][Full Text] [Related]
10. Identification of potential microRNA markers related to Crimean-Congo hemorrhagic fever disease. Arslan S; Engin A; Aydemir EI; Sahin NO; Bayyurt B; Sari I; Cosgun Y; Bakir M J Cell Biochem; 2019 Sep; 120(9):15506-15517. PubMed ID: 31044455 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of viral load in Crimean Congo hemorrhagic fever. Hasanoglu I; Guner R; Carhan A; K Tufan Z; Y Caglayik D; Yilmaz GR; Tasyaran MA J Med Virol; 2018 Apr; 90(4):639-643. PubMed ID: 29091325 [TBL] [Abstract][Full Text] [Related]